Trading Information Summary - On February 4, 2026, Chen Guang Medical (920300) closed at 14.87 yuan, up 0.95%, with a turnover rate of 2.01% and a trading volume of 13,400 shares, amounting to a transaction value of 19.9093 million yuan [1]. - On the same day, the net inflow of main funds was 283,700 yuan, accounting for 1.42% of the total transaction value; the net inflow of speculative funds was 456,500 yuan, accounting for 2.29%; while retail investors had a net outflow of 1.2111 million yuan, accounting for 6.08% [1][3]. Shareholder Changes - On February 4, 2026, Chen Guang Medical announced that its shareholder Tian Lifeng reduced her holdings by a total of 70,000 shares from January 10 to January 14, 2026, which accounted for 0.0815% of the company's total share capital. During this period, the stock price increased by 7.42%, closing at 17.38 yuan on January 14 [1]. - Tian Lifeng cumulatively reduced her holdings by 226,501 shares between November 13, 2025, and January 14, 2026, representing 0.2638% of the total share capital, with a reduction price range of 14.99 to 18.01 yuan per share, totaling 3.875 million yuan. After this reduction, her shareholding decreased to 4,678,693 shares, representing 5.4500% of the total share capital. The reduction plan has not been completed, and the reduction period has expired, consistent with previous disclosures [1][3].
股市必读：2月4日辰光医疗发布公告，股东减持7万股